Ameliorating Cardiovascular Risk in Patients with Type 2 Diabetes

被引：3
|
作者：
Motairek, Issam [1 ]
Al-Kindi, Sadeer [1 ]
机构：
[1] Case Western Reserve Univ, Univ Hosp Harrington Heart & Vasc Inst, Sch Med, 11100 Euclid Ave, Cleveland, OH 44106 USA
来源：
ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA | 2023年 / 52卷 / 01期
关键词：
Cardiovascular disease; Type 2 diabetes mellitus; Risk factors; PRIMARY PREVENTION; GLYCEMIC CONTROL; DISEASE; OUTCOMES; THERAPY; ADULTS; INTERVENTIONS; COMPLICATIONS; METAANALYSIS; ASSOCIATION;
D O I：
10.1016/j.ecl.2022.07.002
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：135 / 147
页数：13
相关论文
共 50 条
  • [31] Metabolic syndrome as a cardiovascular risk factor in patients with type 2 diabetes
    Orna, JAG
    Arnal, LML
    Herguedas, EM
    Julián, BB
    Córdoba, DPP
    REVISTA ESPANOLA DE CARDIOLOGIA, 2004, 57 (06): : 507 - 513
  • [32] Kidney function and the risk of cardiovascular disease in patients with type 2 diabetes
    Wang, Yujie
    Katzmarzyk, Peter T.
    Horswell, Ronald
    Zhao, Wenhui
    Johnson, Jolene
    Hu, Gang
    KIDNEY INTERNATIONAL, 2014, 85 (05) : 1192 - 1199
  • [33] Risk Factors and cardiovascular Outcomes in Patients with type 2 Diabetes Mellitus
    Pavlicek, Vojtech
    DIABETOLOGE, 2018, 14 (07): : 499 - 500
  • [34] The validation of cardiovascular risk scores for patients with type 2 diabetes mellitus
    van der Leeuw, J.
    van Dieren, S.
    Beulens, J. W. J.
    Boeing, H.
    Spijkerman, A. M. W.
    van der Graaf, Y.
    van der A, D. L.
    Noethlings, U.
    Visseren, F. L. J.
    Rutten, G. E. H. M.
    Moons, K. G. M.
    van der Schouw, Y. T.
    Peelen, L. M.
    HEART, 2015, 101 (03) : 222 - 229
  • [35] ASSESSMENT OF CARDIOVASCULAR DISEASES RISK IN PATIENTS WITH TYPE 2 DIABETES MELLITUS
    Jose, C.
    VALUE IN HEALTH, 2017, 20 (05) : A351 - A351
  • [36] Evaluation of Residual Cardiovascular Risk in Patients With Type 2 Diabetes Mellitus
    Reingold, Jason S.
    Nasir, Khurram
    Patel, Neel R.
    Pourfarzib, Ray
    Winegar, Deborah
    DIABETES, 2013, 62 : A614 - A615
  • [37] Sleep Apnea and Cardiovascular Risk in Patients with Prediabetes and Type 2 Diabetes
    Paschou, Stavroula A.
    Bletsa, Evanthia
    Saltiki, Katerina
    Kazakou, Paraskevi
    Kantreva, Kanella
    Katsaounou, Paraskevi
    Rovina, Nikoletta
    Trakada, Georgia
    Bakakos, Petros
    Vlachopoulos, Charalambos V.
    Psaltopoulou, Theodora
    NUTRIENTS, 2022, 14 (23)
  • [38] Seasonal variation in estimated cardiovascular risk in patients with type 2 diabetes
    Ciardullo, Stefano
    Muraca, Emanuele
    Cannistraci, Rosa
    Manzoni, Giuseppina
    Perra, Silvia
    Bianconi, Eleonora
    Oltolini, Alice
    Zerbini, Francesca
    Grassi, Guido
    Mancia, Giuseppe
    Lattuada, Guido
    Perseghin, Gianluca
    NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES, 2021, 31 (05) : 1494 - 1500
  • [39] Cardiologists' approach to managing cardiovascular risk in patients with type 2 diabetes
    Rocha, Natalia
    Das, Sandeep R.
    JOURNAL OF DIABETES, 2019, 11 (07) : 605 - 609
  • [40] Osteprotegerin as cardiovascular risk marker in patients with type 2 diabetes mellitus
    Rozas-Moreno, P.
    Munoz-Torres, M.
    Alonso, G.
    Fernandez-Garcia, D.
    Luque-Fernandez, I.
    Sebastian-Ochoa, A.
    Escobar-Jimenez, F.
    JOURNAL OF BONE AND MINERAL RESEARCH, 2007, 22 : S271 - S271
12345